|
|
|
|
Small Stocks, Big Money™
|
|
Weekly Newsletter
|
|
|
|
|
|
|
|
Calidi Biotherapeutics Establishes Elite Scientific Advisory Board to Accelerate Genetic Medicine Platform and CLD-401 Development
Calidi Biotherapeutics (NYSE American: CLDI) has established a high-powered Scientific Advisory Board to guide the clinical advancement of CLD-401 and its proprietary RedTail platform, an engineered virotherapy approach designed for systemic delivery of targeted genetic medicine. The board includes leaders in oncology, virotherapy, and immunotherapy, such as former Pfizer CMO Dr. Mace Rothenberg and IL-15 superagonist expert Dr. John Wrangle, bolstering Calidi’s mission to transform treatment for metastatic cancers with its CD55-modified oncolytic virus technology.
|
|
|
|
Gorilla Technology Expands Share Buyback to $20M, Underscoring Confidence in Undervalued Stock
Gorilla Technology (Nasdaq: GRRR) has boosted its share repurchase program to $20 million, signaling strong belief in its intrinsic value amid recent $1.4 billion AI data center wins and cutting-edge post-quantum cybersecurity initiatives. Backed by over $100 million in free cash, the company is also preparing to act swiftly post-blackout period if its stock remains undervalued, while pursuing regulatory channels to address suspected short-selling activity.
|
|
|
|
|
NioCorp and Lockheed Martin Join Forces on Pentagon-Backed Scandium Defense Initiative
NioCorp (Nasdaq: NB) has secured Pentagon funding to co-develop a scandium-based defense technology with Lockheed Martin’s Skunk Works®, aiming to prototype aluminum-scandium alloy components for next-gen fighter aircraft. Backed by a $10 million Title III Defense Production Act award, the initiative underscores the strategic importance of NioCorp’s Elk Creek Project, which is set to produce ~100 tonnes of scandium oxide annually—poised to establish the first U.S. mine-to-alloy supply chain for this critical mineral.
|
|
|
|
|
|
|
Bimergen Energy Appoints Co-CEOs to Lead $1B+ Battery Storage Growth Strategy
Bimergen Energy (OTCQB: BESS) has named Cole Johnson and Robert Brilon as Co-CEOs to steer the company through its next phase of expansion, following the successful securing of $250 million in mezzanine and equity financing. With a combined leadership background in energy development, corporate finance, and public company operations, the duo will drive Bimergen’s plan to bring 23 utility-scale battery storage projects—totaling 2 GW—into commercial operation, unlocking over $1 billion in Tier-1 capacity and revenue upside.
|
|
|
|
|
FatPipe Completes $1.4M SD-WAN Rollout Across 210+ Sites for Major U.S. School District
FatPipe (Nasdaq: FATN) has successfully deployed its SD-WAN solution across more than 210 sites for a large U.S. school district under a $1.4 million contract, unifying classrooms, offices, and data centers under a centralized, high-performance network architecture. The rollout highlights FatPipe’s growing footprint in the education sector and its ability to execute enterprise-scale deployments efficiently—positioning the company to capitalize on rising demand in the SD-WAN and SASE markets.
|
|
|
Recent News
|
RedChip TV
|
|
|
|
RedChip Highlights Bullfrog AI (NASDAQ: BFRG) & Bimergen Energy (OTCQB: BESS)
|
|
|
|
|
|
|
|
|
|
Unlock Smarter Investing with RedChat
|
|
|
Tired of sifting through endless filings? Let RedChat do the heavy lifting. Get real-time, data-driven insights on over 2,000 small-cap stocks—instantly. Save time, make informed decisions, and stay ahead of the market.
|
|
Access RedChat now, free of charge.
|
|
|
|
|
Recent Research Coverage Updates
| Company |
Rating |
Price Target |
Firm |
Report Date |
| NioCorp (Nasdaq: NB) |
Buy |
$15 |
Maxim |
October 15, 2025 |
| NioCorp (Nasdaq: NB) |
Buy |
$8 |
H.C. Wainwright |
September 22, 2025 |
| Alliance Entertainment (Nasdaq: AENT) |
Buy |
$11 |
Noble Capital |
October 6, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$4 |
Maxim |
September 22, 2025 |
| XORTX Therapeutics (Nasdaq: XRTX) |
Buy |
$14 |
AGP |
September 18, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$10 |
H.C. Wainwright |
September 12, 2025 |
| Alliance Entertainment (Nasdaq: AENT) |
Buy |
$10 |
Maxim |
September 11, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$16 |
D Boral |
September 10, 2025 |
| Greenwich LifeSciences (Nasdaq: GLSI) |
Buy |
$45 |
Noble |
August 20, 2025 |
| Nexalin Technology (Nasdaq: NXL) |
Buy |
$4 |
Maxim |
August 19, 2025 |
| Atossa Therapeutics (Nasdaq: ATOS) |
Buy |
$7 |
HC Waingwright |
August 12, 2025 |
| Atossa Therapeutics (Nasdaq: ATOS) |
Buy |
$4 |
Maxim |
August 12, 2025 |
| Atossa Therapeutics (Nasdaq: ATOS) |
Buy |
$4 |
Maxim |
August 12, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$16 |
D Boral |
July 29, 2025 |
| Connect Biopharma (Nasdaq: CNTB) |
Buy |
$7.5 |
Northland Securities |
July 23, 2025 |
| Connect Biopharma (Nasdaq: CNTB) |
Buy |
$4 |
Titan Partners |
July 17, 2025 |
| NioCorp (Nasdaq: NB) |
Buy |
$5 |
Maxim |
July 10, 2025 |
| Connect Biopharma (Nasdaq: CNTB) |
Buy |
$7 |
H.C. Wainwright |
July 9, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$16 |
D Boral |
July 9, 2025 |
| NioCorp (Nasdaq: NB) |
Buy |
$4 |
HC Wainwright |
July 2, 2025 |
| Alliance Entertainment (Nasdaq: AENT) |
Buy |
$10 |
Maxim |
July 1, 2025 |
|
|
|
|
|
|
Small Stocks, Big Money™ Podcast
|
|
The podcast features in-depth interviews with CEO's from the top names in small-cap stocks, providing listeners with a unique perspective not found anywhere else.
|
|
Available on:
|
|
|
|
|
|
|
Upcoming Events
|
|
|
NioCorp Developments (NASDAQ: NB)
4:15pm Eastern
NioCorp is developing the Elk Creek Project that is expected to produce niobium, scandium, and titanium. The Company also is evaluating the potential to produce several rare earths from the Elk Creek Project.
|
|
|
|
ASP Isotopes (NASDAQ: ASPI)
04:15pm Eastern
This exclusive event will provide investors with an opportunity to gain critical insights into ASP Isotopes' strategic initiatives and technological advancements.
|
|
|
|
NASDAQ: NXL - Nexalin Technology
4:15pm Eastern
Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic.
|
|
|
|
BullFrog AI (NASDAQ: BFRG)
4:15pm Eastern
BullFrog AI, a US-company headquartered in Maryland, is revolutionizing drug discovery and development with BullFrog Data Networks®, a cutting-edge platform powered by its proprietary bfLEAP® technology.
|
|
|
|
Archived Events
|
|
|
60 Degrees Pharmaceuticals (NASDAQ: SXTP)
4:15pm Eastern
60 Degrees Pharmaceuticals (60P) is a growth-oriented biotechnology company with a goal of using cutting-edge biological science and applied research to further develop and commercialize new therapies for the prevention and treatment of infectious diseases.
|
|
|
|
Quote of the Week
|
" Higher returns, of course, come with more risk...the trade-off is, yes, you get long-term out-performance ... but the volatility of returns is greater...That's the price you pay if you want exposure to a better-performing asset class."
|
|
|
— Samuel Dedio, Manager of the Artio U.S. Microcap Fund
|
|
|
|
|
Order "Small Stocks, Big Money™ Today!
Dave Gentry's new book, Small Stocks, Big Money: Interviews With Microcap Superstars, is now available for pre-order. Published by Wiley Finance, this first-hand perspective and insider information on the fast world of microcap investing is now available for purchase.
|
|
|
|
|
|
|
Lesson of the Week
Learn what the fifth letter of a stock symbol means.
|
|
|
|
|
|
|
